共 50 条
- [41] Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome EDITORIAL COMMENT JOURNAL OF UROLOGY, 2017, 198 (02): : 374 - 374
- [43] Re: Long-Term Outcome of the Use of Intravesical Botulinum Toxin for the Treatment of Overactive Bladder (OAB) Editorial Comment JOURNAL OF UROLOGY, 2013, 190 (05): : 1815 - 1815
- [44] Long term outcomes of cystectomy with bladder substitution in the treatment of advanced interstitial cystitis/bladder pain syndrome: A retrospective cohort series JOURNAL OF UROLOGY, 2008, 179 (04): : 246 - 247
- [45] Re: Long-Term Ketamine Abuse Induces Cystitis in Rats by Impairing the Bladder Epithelial Barrier Editorial Comment JOURNAL OF UROLOGY, 2016, 195 (01): : 222 - 222
- [46] Re: Prognostic Factors for Recent-Onset Interstitial Cystitis/Painful Bladder Syndrome Editorial Comment JOURNAL OF UROLOGY, 2013, 190 (02): : 551 - 551
- [47] Food Sensitivities in a Diverse Nationwide Cohort of Veterans With Interstitial Cystitis/Bladder Pain Syndrome EDITORIAL COMMENT JOURNAL OF UROLOGY, 2023, 209 (01): : 224 - 224
- [49] Trigonal Injection of Botulinum Toxin A in Patients With Refractory Bladder Pain Syndrome/Interstitial Cystitis Editorial Comment JOURNAL OF UROLOGY, 2010, 184 (04): : 1364 - 1365